- Home
- GEHC vs LVS Comparison
GEHC vs LVS Comparison
Compare GEHC & LVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEHC
- LVS
- Stock Information
- Founded
- GEHC 1892
- LVS 1988
- Country
- GEHC United States
- LVS United States
- Employees
- GEHC N/A
- LVS N/A
- Industry
- GEHC Computer Software: Prepackaged Software
- LVS Hotels/Resorts
- Sector
- GEHC Technology
- LVS Consumer Discretionary
- Exchange
- GEHC Nasdaq
- LVS Nasdaq
- Market Cap
- GEHC 36.2B
- LVS 34.2B
- IPO Year
- GEHC N/A
- LVS 2004
- Fundamental
- Price
- GEHC $87.34
- LVS $45.37
- Analyst Decision
- GEHC Buy
- LVS Buy
- Analyst Count
- GEHC 14
- LVS 14
- Target Price
- GEHC $96.00
- LVS $60.08
- AVG Volume (30 Days)
- GEHC 3.2M
- LVS 3.7M
- Earning Date
- GEHC 02-13-2025
- LVS 01-27-2025
- Dividend Yield
- GEHC 0.16%
- LVS 1.77%
- EPS Growth
- GEHC 8.27
- LVS 133.34
- EPS
- GEHC 3.65
- LVS 2.02
- Revenue
- GEHC $19,559,000,000.00
- LVS $11,317,000,000.00
- Revenue This Year
- GEHC $2.70
- LVS $10.21
- Revenue Next Year
- GEHC $3.90
- LVS $9.68
- P/E Ratio
- GEHC $23.93
- LVS $22.46
- Revenue Growth
- GEHC 1.43
- LVS 31.99
- 52 Week Low
- GEHC $71.31
- LVS $36.62
- 52 Week High
- GEHC $94.55
- LVS $56.61
- Technical
- Relative Strength Index (RSI)
- GEHC 66.03
- LVS 33.36
- Support Level
- GEHC $82.86
- LVS $43.78
- Resistance Level
- GEHC $86.25
- LVS $51.98
- Average True Range (ATR)
- GEHC 2.06
- LVS 1.33
- MACD
- GEHC 0.68
- LVS -0.57
- Stochastic Oscillator
- GEHC 97.21
- LVS 19.39
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
About LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and VICI in 2022. With the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.